Structure |
Chemical Name |
CAS |
MF |
|
LDN-57444 |
668467-91-2 |
C17H11Cl3N2O3 |
|
P-5091 |
882257-11-6 |
C12H7Cl2NO3S2 |
|
1-[1-(4-Fluorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]-2-(1-pyrrolidinyl)ethanone |
314245-33-5 |
C18H21FN2O |
|
SANT-1 |
304909-07-7 |
C23H27N5 |
|
BMS 833923 |
1059734-66-5 |
C30H27N5O |
|
2,2'-[[Dihydro-2-(4-pyridinyl)-1,3(2H,4H)-pyrimidinediyl]bis(methylene)]bis[N,N-dimethylbenzenamine |
500579-04-4 |
C27H35N5 |
|
Glasdegib |
1095173-27-5 |
C21H22N6O |
|
IMD-0354 |
978-62-1 |
C15H8ClF6NO2 |
|
BAY 11-7085 |
196309-76-9 |
C13H15NO2S |
|
TPCA-1 |
507475-17-4 |
C12H10FN3O2S |
|
SC-514 |
354812-17-2 |
C9H8N2OS2 |
|
2-(5-Benzo[1,3]dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrate hydrochloride |
694433-59-5 |
C20H21N3O2 |
|
AZD-1208 |
1204144-28-4 |
C21H21N3O2S |
|
SGI-1776 |
1025065-69-3 |
C20H22F3N5O |
|
GO 6983 |
133053-19-7 |
C26H26N4O3 |
|
3-(1H-Indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione |
425637-18-9 |
C25H22N6O2 |
|
RO-31-8220 |
138489-18-6 |
C25H23N5O2S |
|
KGN |
4727-31-5 |
C20H15NO3 |
|
2-(4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy)ethanol |
128607-22-7 |
C24H23ClO2 |
|
PF03716556 |
928774-43-0 |
C22H26N4O3 |
|
CFTRinh-172 |
307510-92-5 |
C18H10F3NO3S2 |
|
SCH772984 |
942183-80-4 |
C33H33N9O2 |
|
IWP-2 |
686770-61-6 |
C22H18N4O2S3 |
|
SB 225002 |
182498-32-4 |
C13H10BrN3O4 |
|
SKI II |
312636-16-1 |
C15H11ClN2OS |
|
S3I-201 |
501919-59-1 |
C16H15NO7S |
|
JAK3 Inhibitor |
211555-04-3 |
C16H14BrN3O3 |
|
CP 945598 hydrochloride |
686347-12-6 |
C25H26Cl3N7O |
|
Tezacaftor |
1152311-62-0 |
C26H27F3N2O6 |
|
Zibotentan (ZD4054) |
186497-07-4 |
C19H16N6O4S |
|
ICG-001 |
780757-88-2 |
C33H32N4O4 |
|
Galeterone |
851983-85-2 |
C26H32N2O |
|
Erteberel (LY500307) |
533884-09-2 |
C18H18O3 |
|
AZD3514 |
1240299-33-5 |
C25H32F3N7O2 |
|
KPT-185 |
1333151-73-7 |
C16H16F3N3O3 |
|
GLPG0634 |
1206101-20-3 |
C23H18N6O2 |
|
5-chloro-3-ethyl-1H-indole-2-carboxylic acid [2-(4-piperidin-1-yl-phenyl)-ethyl]-amide |
868273-06-7 |
C24H28ClN3O |
|
MK 3207 hydrochloride |
957116-20-0 |
C31H30ClF2N5O3 |
|
iOWH-032 |
1191252-49-9 |
C22H15Br2N3O4 |
|
(R,S)-AM1241 |
444912-48-5 |
C22H22IN3O3 |
|
N-(3-Cyano-4,5,6,7-tetrahydrobenzo[b]thienyl-2-yl)-1-naphthalenecarboxamide |
312917-14-9 |
C20H16N2OS |
|
Filgotinib |
1206161-97-8 |
C21H23N5O3S |
|
FH 535 |
108409-83-2 |
C13H10Cl2N2O4S |
|
Wnt-C59 |
1243243-89-1 |
C25H21N3O |
|
LCZ696 |
936623-90-4 |
C48H58N6O8 |
|
Stattic |
19983-44-9 |
C8H5NO4S |
|
IWR-1-endo |
1127442-82-3 |
C25H19N3O3 |
|
WP1066 |
857064-38-1 |
C17H14BrN3O |
|
PACRITINIB |
937272-79-2 |
C28H32N4O3 |
|
(-)-Blebbistatin |
856925-71-8 |
C18H16N2O2 |
|
Plinabulin(NPI-2358) |
714272-27-2 |
C19H20N4O2 |
|
OMecaMtiv Mecarbil |
873697-71-3 |
C20H24FN5O3 |
|
KY0211 |
1118807-13-8 |
C18H17ClN2O3S |
|
KI16425 |
355025-24-0 |
C23H23ClN2O5S |
|
NU1025 |
90417-38-2 |
C9H8N2O2 |
|
VX 702 |
745833-23-2 |
C19H12F4N4O2 |
|
PH 797804 |
586379-66-0 |
C22H19BrF2N2O3 |
|
RN486 |
1242156-23-5 |
C35H35FN6O3 |
|
Ilomastat |
142880-36-2 |
C20H28N4O4 |
|
RO4929097 |
847925-91-1 |
C22H20F5N3O3 |
|
PD318088 |
391210-00-7 |
C16H13BrF3IN2O4 |
|
Birinapant |
1260251-31-7 |
C42H56F2N8O6 |
|
Batimastat |
130370-60-4 |
C23H31N3O4S2 |
|
LY411575 |
209984-57-6 |
C26H23F2N3O4 |
|
AZ 628 |
878739-06-1 |
C27H25N5O2 |
|
BMN 673 |
1207456-01-6 |
C19H14F2N6O |
|
ONX-0914 |
960374-59-8 |
C31H40N4O7 |
|
Marimastat |
154039-60-8 |
C15H29N3O5 |
|
Nutlin 3a |
675576-98-4 |
C30H30Cl2N4O4 |
|
Tenovin-6 |
1011557-82-6 |
C25H34N4O2S |
|
WH-4-023 |
837422-57-8 |
C32H36N6O4 |
|
PJ-34 |
344458-19-1 |
C17H17N3O2 |
|
Pifithrin-μ |
64984-31-2 |
C8H7NO2S |
|
SL 327 |
305350-87-2 |
C16H12F3N3S |
|
5-(2-Oxo-2-phenylethoxy)-3,4-dihydroisoquinolin-1(2H)-one |
1048371-03-4 |
C17H13NO3 |
|
TAK-733 |
1035555-63-5 |
C17H15F2IN4O4 |
|
E-64C |
76684-89-4 |
C15H26N2O5 |
|
VX-222 |
1026785-59-0 |
C25H35NO4S |
|
KU-60019 |
925701-49-1 |
C30H33N3O5S |
|
BIX 02189 |
1094614-85-3 |
C27H28N4O2 |
|
Oprozomib |
935888-69-0 |
C25H32N4O7S |
|
Skepinone-L |
1221485-83-1 |
C24H21F2NO4 |
|
TAK-632 |
1228591-30-7 |
C27H18F4N4O3S |
|
2-[[(2E)-3-(2-NAPHTHALENYL)-1-OXO-2-BUTEN-1-YL]AMINO]BENZOIC ACID |
321674-73-1 |
C21H17NO3 |
|
CX-5461 |
1138549-36-6 |
C27H27N7O2S |
|
7Methyl-5-(1-{[3-(trifluoroMethyl)phenyl]acetyl}-2,3-dihydro1Hindol-5-yl)7Hpyrrolo[2,3d]pyriMidin-4-aMine |
1337531-36-8 |
C24H20F3N5O |
|
LCL-161 |
1005342-46-0 |
C26H33FN4O3S |
|
AZD2461 |
1174043-16-3 |
C22H22FN3O3 |
|
Tasisulam |
519055-62-0 |
C11H6BrCl2NO3S2 |
|
YK-4-279 |
1037184-44-3 |
C17H13Cl2NO4 |
|
Imidazo[4,5,1-jk][1,4]benzodiazepin-7(4H)-one, 2-[4-[(dimethylamino)methyl]phenyl]-5,6-dihydro- |
328543-09-5 |
C19H20N4O |
|
U0126-EtOH |
1173097-76-1 |
C20H22N6OS2 |
|
ETP46464 |
1345675-02-6 |
C30H22N4O2 |
|
UNC-1215 |
1415800-43-9 |
C32H43N5O2 |
|
LY2228820 |
862507-23-1 |
C26H37FN6O6S2 |
|
N-[3-[4,5-Dihydro-4-methyl-6-[[4-(4-morpholinylcarbonyl)phenyl]amino]-5-oxo-2-pyrazinyl]-2-methylphenyl]-4-(tert-butyl)benzamide |
910232-84-7 |
C34H37N5O4 |
|
Binimetinib |
606143-89-9 |
C17H15BrF2N4O3 |
|
3,4-Dichloro-N-(1-Methylbutyl)benza-Mide |
7497-07-6 |
C12H15Cl2NO |
|
NU7026 |
154447-35-5 |
C17H15NO3 |
|
CP466722 |
1080622-86-1 |
C17H15N7O2 |